MedTrace Logo

The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients

NCT02391818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2019-08-28

No results posted yet for this study

Summary

The purpose of this study is to quantify the balance impairments during and after taxane chemotherapy. Disability due to balance impairments caused by chemotherapy induced peripheral neuropathy (CIPN) can cause falls, injury, and a decline in independence. This results in poor treatment outcomes such as greater morbidity and mortality, inability to complete treatment protocols, self-limitation of activity, and diminished quality of life.

Conditions

Sponsors & Collaborators

  • Illinois CancerCare, P.C.

    collaborator OTHER

  • University of Illinois College of Medicine at Peoria

    collaborator OTHER

  • St. Francis Hospitals & Health Centers

    collaborator OTHER

  • OSF Healthcare System

    lead OTHER

Principal Investigators

  • Carl Asche, PhD · University of Illinois College of Medicine at Peoria

  • Jinma Ren, PhD · University of Illinois College of Medicine at Peoria

  • Catherine Horst, DPT · IPMR

  • Nguyet Le-Lindqwister, MD · Illinois CancerCare

  • Anthony Zalduendo, MD · OSF Radiation Oncology

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-06-16
Completion
2017-06-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02391818 on ClinicalTrials.gov